2015
DOI: 10.1186/s12958-015-0024-1
|View full text |Cite
|
Sign up to set email alerts
|

Menstrual cycle length: a surrogate measure of reproductive health capable of improving the accuracy of biochemical/sonographical ovarian reserve test in estimating the reproductive chances of women referred to ART

Abstract: BackgroundAim of the study was to investigate whether menstrual cycle length may be considered as a surrogate measure of reproductive health, improving the accuracy of biochemical/sonographical ovarian reserve test in estimating the reproductive chances of women referred to ART.MethodsA retrospective-observational-study in Padua’ public tertiary level Centre was conducted. A total of 455 normo-ovulatory infertile women scheduled for their first fresh non-donor IVF/ICSI treatment. The mean menstrual cycle lengt… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
30
0
1

Year Published

2015
2015
2021
2021

Publication Types

Select...
10

Relationship

5
5

Authors

Journals

citations
Cited by 29 publications
(31 citation statements)
references
References 29 publications
0
30
0
1
Order By: Relevance
“…This enables the recruitment and support of all 'responder' follicles until the pre ovulatory phase. Therefore, the substrate of FSH action depends only on the number of primordial and primary follicles available in the ovarian cortex at the beginning of the cycle ( 26 ).…”
Section: Discussionmentioning
confidence: 99%
“…This enables the recruitment and support of all 'responder' follicles until the pre ovulatory phase. Therefore, the substrate of FSH action depends only on the number of primordial and primary follicles available in the ovarian cortex at the beginning of the cycle ( 26 ).…”
Section: Discussionmentioning
confidence: 99%
“…It is important to remember that AFC is only a surrogate of ovarian reserve that should be interpreted ideally in association with basal AMH, FSH and chronological age [3941]. Trials investigating variations in ovarian reserve determined by the combination of both AFC and biochemical assay of FSH and AMH levels seems to suggest a non-significant reduction in the cohort of treated patients compared to controls [8, 16, 17, 2023, 2527, 31].…”
Section: Discussionmentioning
confidence: 99%
“…Patients in groups A and B will be treated with GnRH-antagonist (short protocol) stimulation according to our Units Protocol ( 25 , 26 ). All stimulation cycles will be performed using 350 IU rFSH (Gonal F; Merck Serono S.A., Geneva, Switzerland) daily for the first 5 days.…”
Section: Methodsmentioning
confidence: 99%